These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7788624)

  • 41. Peripheral hormonal responses to D-fenfluramine as a probe of central serotonergic function in humans.
    Abel KM; Cleare AJ
    Psychopharmacology (Berl); 1999 Feb; 142(1):68-72. PubMed ID: 10102784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroendocrine aspects of chronic fatigue syndrome.
    Papanicolaou DA; Amsterdam JD; Levine S; McCann SM; Moore RC; Newbrand CH; Allen G; Nisenbaum R; Pfaff DW; Tsokos GC; Vgontzas AN; Kales A
    Neuroimmunomodulation; 2004; 11(2):65-74. PubMed ID: 14758052
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fenfluramine challenge test as a marker of serotonin activity in patients with Alzheimer's dementia and agitation.
    Mintzer J; Brawman-Mintzer O; Mirski DF; Unger R; Nietert P; Meeks A; Sampson R
    Biol Psychiatry; 1998 Nov; 44(9):918-21. PubMed ID: 9807649
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Do noradrenergic reuptake inhibitors affect serotonergic function in depression?
    Cleare AJ; Murray RM; O'Keane V
    Psychopharmacology (Berl); 1997 Dec; 134(4):406-10. PubMed ID: 9452184
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral D-fenfluramine and neuroendocrine challenge: problems with the 30 mg dose in men.
    Goodwin GM; Murray CL; Bancroft J
    J Affect Disord; 1994 Feb; 30(2):117-22. PubMed ID: 8201126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression.
    Cleare AJ; McGregor A; O'Keane V
    Clin Endocrinol (Oxf); 1995 Dec; 43(6):713-9. PubMed ID: 8736274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome.
    Kavelaars A; Kuis W; Knook L; Sinnema G; Heijnen CJ
    J Clin Endocrinol Metab; 2000 Feb; 85(2):692-6. PubMed ID: 10690878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Test-retest reliability of the prolactin and cortisol responses to D,L-fenfluramine challenge in disruptive behavior disorders.
    Stoff DM; Pasatiempo AP; Yeung JH; Bridger WH; Rabinovich H
    Psychiatry Res; 1992 Apr; 42(1):65-72. PubMed ID: 1603882
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serotonergic function in panic disorder: endocrine responses to D-fenfluramine.
    Judd FK; Apostolopoulos M; Burrows GD; Norman TR
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar; 18(2):329-37. PubMed ID: 8208982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decreased tryptophan availability but normal post-synaptic 5-HT2c receptor sensitivity in chronic fatigue syndrome.
    Vassallo CM; Feldman E; Peto T; Castell L; Sharpley AL; Cowen PJ
    Psychol Med; 2001 May; 31(4):585-91. PubMed ID: 11352361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hormonal responses to exercise in chronic fatigue syndrome.
    Ottenweller JE; Sisto SA; McCarty RC; Natelson BH
    Neuropsychobiology; 2001 Jan; 43(1):34-41. PubMed ID: 11150897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuroendocrine responses to fenfluramine and its relationship to personality in alcoholism.
    Weijers HG; Wiesbeck GA; Jakob F; Böning J
    J Neural Transm (Vienna); 2001; 108(8-9):1093-105. PubMed ID: 11716144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diazepam alters brain 5-HT function in man: implications for the acute and chronic effects of benzodiazepines.
    Nutt DJ; Cowen PJ
    Psychol Med; 1987 Aug; 17(3):601-7. PubMed ID: 3628621
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased brain serotonin function in men with chronic fatigue syndrome.
    Sharpe M; Hawton K; Clements A; Cowen PJ
    BMJ; 1997 Jul; 315(7101):164-5. PubMed ID: 9251547
    [No Abstract]   [Full Text] [Related]  

  • 55. Neuroendocrine aspects of chronic fatigue syndrome: a commentary.
    Demitrack MA
    Am J Med; 1998 Sep; 105(3A):11S-14S. PubMed ID: 9790476
    [No Abstract]   [Full Text] [Related]  

  • 56. Prolactin response to dl-fenfluramine in panic disorder.
    Apostolopoulos M; Judd FK; Burrows GD; Norman TR
    Psychoneuroendocrinology; 1993; 18(5-6):337-42. PubMed ID: 8416044
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Usefulness of growth chart in children and adolescents with chronic fatigue syndrome].
    Oki J; Okubo J
    Nihon Rinsho; 2007 Jun; 65(6):1113-9. PubMed ID: 17561706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome.
    Bakheit AM; Behan PO; Dinan TG; Gray CE; O'Keane V
    BMJ; 1992 Apr; 304(6833):1010-2. PubMed ID: 1586780
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies.
    Sobczak S; Honig A; van Duinen MA; Riedel WJ
    Bipolar Disord; 2002 Dec; 4(6):347-56. PubMed ID: 12519094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurobiological aspects of the chronic fatigue syndrome.
    Bearn J; Wessely S
    Eur J Clin Invest; 1994 Feb; 24(2):79-90. PubMed ID: 8206084
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.